Variations in the Promoter Region of the Apolipoprotein A-1 Gene Influence Plasma Lipoprotein(A)

Total Page:16

File Type:pdf, Size:1020Kb

Variations in the Promoter Region of the Apolipoprotein A-1 Gene Influence Plasma Lipoprotein(A) 0031-3998/01/4904-0514 PEDIATRIC RESEARCH Vol. 49, No. 4, 2001 Copyright © 2001 International Pediatric Research Foundation, Inc. Printed in U.S.A. Variations in the Promoter Region of the Apolipoprotein A-1 Gene Influence Plasma Lipoprotein(a) Levels in Asian Indian Neonates from Singapore CHEW-KIAT HENG, POH-SIM LOW, AND NILMANI SAHA Department of Paediatrics, National University of Singapore, Singapore 119074 ABSTRACT We studied the influence of two DNA polymorphisms (Ϫ75 levels were also significantly different between composite geno- bp G/A and ϩ83 bp C/T) in the promoter region of the apoli- types in the order GG/TT Ͼ GA/CT Ͼ GG/CT Ͼ GA/CC Ͼ poprotein A-1 (apoA1) gene on cord plasma level of lipopro- GG/CC Ͼ AA/CC. The effects of the two polymorphisms seem to tein(a) [Lp(a)] in 1076 newborns of both genders from the three be additive as the composite genotypes were able to explain 14% major ethnic groups in Singapore—Chinese, Malays, and Asian of the Lp(a) variance, equivalent to the sum of the two constit- Indians. The frequency of the A allele at Ϫ75 bp in the Indians uent sites. Our results showed that there is significant ethnic- and was significantly lower than the Chinese and Malays. There was gender-specific influence of the apoA1 gene on plasma Lp(a) no linkage disequilibrium between the two sites studied. Both levels at birth that is inherent and independent of known gene- polymorphic sites were not significantly associated with any lipid environment interactions. (Pediatr Res 49: 514–518, 2001) factors except for Lp(a) levels in the Asian Indians. The AA and CC homozygotes were significantly associated with lower Lp(a) levels. These associations were specific only to the male Indian Abbreviations neonates. The genetic variations at the Ϫ75 and ϩ83 bp ex- apoA1, apolipoprotein A-1 plained 6.9% and 7.2%, respectively, of the total variability of Lp(a), lipoprotein(a) plasma Lp(a) levels at birth in the Asian Indians. The Lp(a) CAD, coronary artery disease ApoA1 is the predominant protein that is associated with the The gene for apoA1 is located on the long arm of chromo- HDL cholesterol (HDLC) particle. Both HDLC and apoA1 are some 11 together with the apolipoprotein C-3 and apolipopro- key components of the reverse cholesterol transport process tein A-4 genes (12, 13). A common polymorphism described in and are inversely correlated with the risk of CAD. the apoA1 promoter region consists of a G to A substitution at Both genetic and environmental factors influence plasma the 75 bp upstream of the transcription start site. Many studies HDLC and apoA1 levels (1, 2). There is evidence to link have found consistent association of this polymorphism with polymorphisms in the apoA1 gene to CAD prevalence and HDLC levels in several populations (14–21) but not in others incidence (3, 4). Population and clinical studies suggest a (22–24). ApoA1 production rate was shown to be significantly major locus involved in the control of plasma HDLC and lower in G/A human subjects than GG homozygotes (22). apoA1 (5–8). Recently, however, three groups reported that Lower promoter activity (22) and expression rate (22, 25) were Tangier disease, a rare recessive disorder characterized by an observed in vitro with the A allele. However, another study extremely low HDLC and an apoA1 level of only 2–3% of found that the A allele significantly decreased the binding normal range, is caused by mutations in the ATP-binding affinity of a nuclear factor that enhanced the transcription cassette transporter1 gene (9–11). efficiency of the promoter (26). In a meta-analysis (27) com- prising over 3000 healthy subjects, the rare allele A was associated with mildly increased apoA1 levels of about 5 mg/dL. Received February 24, 2000; accepted November 29, 2000. Correspondence: P.S. Low, Department of Paediatrics, National University of Singa- Recently, another MspI polymorphic site was identified in pore, 5, Lower Kent Ridge Road, Singapore 119074; e-mail: [email protected] the first intron of apoA1 gene, creating a C-T and/or G-A Supported by grant NMRC/0234/1997 from the National Medical Research Council of transition at the ϩ83 bp and/or ϩ84 bp (28). These sequence Singapore. Present affiliation for N.S.: Division of Molecular Genetics, John Curtin School of variations were shown to be associated with increased HDLC Medical Research, The Australian National University, ACT-2601, Australia. levels (29, 30). Both the Ϫ75 bp and ϩ83 bp sites were 514 EFFECT OF APOA1 GENE ON Lp(a) IN NEONATES 515 significantly predictive of CAD severity in terms of the number U.S.A.). The significance of differences for the means of of diseased vessels in a case-control study (31). There was plasma total cholesterol (TC), triglycerides (TG), HDLC, LDL another report of higher A allele frequency in myocardial cholesterol (LDLC), apoA1, apolipoprotein B (apoB), and infarction patients relative to healthy control subjects (32) but Lp(a) levels between races and gender were determined by the not for alleles at the ϩ83 bp. t test or ANOVA as appropriate. Allelic frequencies of the Association studies of apoA1 polymorphisms with lipid apoA1 gene polymorphisms were estimated by gene counting quantitative traits have thus far been carried out in adult and 95% confidence intervals by the following formula: fre- populations. Such studies had to take into consideration the quency Ϯ 1.96 [p(1 Ϫ p)/n]½ where p is the allele frequency confounding nongenetic factors such as effects of smoking, and n is the total number of chromosomes. The ␹2 analysis was diet, and medication on lipid profiles of the subjects. To be free used to test for Hardy-Weinberg equilibrium and the z test for from the confounding effects of the above environmental fac- differences in allele frequencies between groups. Test of inde- tors, we undertook this study with neonatal cord blood samples pendence between the two apoA1 polymorphic sites was also from the Chinese, Malay, and Asian Indian populations of estimated by the ␹2 statistic, and the strength of their associa- Singapore. The Asian Indians will henceforth be referred to as tions (linkage disequilibrium) was determined by the correla- Indians. As cord plasma lipid levels have yet to be influenced tion coefficient, ⌬, according to Chakravarti et al. (36). by any known environmental factors, any genotype-specific ANOVA was performed to determine the effects of the apoA1 association of the apoA1 promoter gene polymorphisms with gene polymorphisms on the various lipid traits in the different cord plasma lipid levels would reflect the extent of genetic ethnic groups after adjustment for significant covariates. The control at birth. significance of the sample variance was tested by F and p values and percentage of explained variance (R2 ϫ 100) was MATERIALS AND METHODS calculated from the sum of squares. Due to skewed distribu- tion, the raw data for TG and Lp(a) were transformed by Study subjects. A sample of 1076 cord blood obtained from natural logarithm before comparison by t test and ANOVA. normal newborns of Chinese, Malay, and Indian heritage were Because the raw values of triglycerides and Lp(a) in cord blood studied. Participating babies had no history of mixed heritage specimens were small, with most values below 1, and as the ln in the preceding three generations. Verbal informed consent of Ͻ1 is negative, logarithmic transformation for these param- was obtained from parents of the newborns for inclusion of eters were carried out following addition of 1 to the raw values. their child for this study. The details of sample collection and Statistical significance was taken at the 0.05 level. methods of lipid and lipoprotein level estimation were as reported in our earlier studies (33, 34). This study was ap- RESULTS proved by the National Medical Research Council of Singapore. The genotype and allelic frequencies of both the apoA1 Isolation of DNA and genotyping of ApoA1 polymor- polymorphisms in the three ethnic groups are presented in phisms. Genomic DNA was extracted from leukocytes ob- Table 1. Genotype distributions were all consistent with a tained from the cord blood samples by the sarcosine method population at Hardy-Weinberg equilibrium except for the ϩ83 (35). The ApoA1 polymorphisms were identified by PCR. A bp site in the Indians. The marginal deviation was due to the 433-bp fragment in the 5' region of the ApoA1 gene was presence of one rare homozygous TT subject. It was not likely amplified by using the following primers: sense, 5' AGG GAC that any of the assumptions for Hardy-Weinberg equilibrium AGA GCT GAT CCT TGA ACT CTT AAG 3' and antisense, were violated, and we attribute such departure from equilib- 5' TTA GGG GAC ACC TAG CCC TCA GGA AGA GCA 3' rium to chance. The allele frequency of A at Ϫ75 bp in the (21). PCR was performed in a volume of 20 ␮L containing Indians was significantly lower than both the Chinese and the 1–10 ␮g of genomic DNA, 20 pmol of each primer, 0.5 mM of Malays, whereas the T allele at ϩ83 bp was significantly lower each deoxyribonucleoside triphosphate (dNTP), reaction than the Chinese only. The two sites were not in linkage buffer, 2% DMSO, and 1.0 U of Taq DNA polymerase. disequilibrium for all ethnic groups. Details of linkage disequi- Amplified products were digested with 10 U of MspI at 37°C librium tests are given in Table 2. overnight and the digested fragments were size-fractionated in Cord plasma Lp(a) levels were not significantly different 2% NuSieve (BioWhittaker, Rockland, ME, U.S.A.) agarose between genders in all the three ethnic groups.
Recommended publications
  • Heterozygous ATP-Binding Cassette Transporter G5 Gene Deficiency and Risk of Coronary Artery Disease
    bioRxiv preprint doi: https://doi.org/10.1101/780734; this version posted September 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Heterozygous ATP-binding Cassette Transporter G5 Gene Deficiency and Risk of Coronary Artery Disease Short title: Heterozygous ABCG5 deficiency and risk of CAD Akihiro Nomura*, MD PhD, Connor A. Emdin*, DPhil, Hong Hee Won, PhD, Gina M. Peloso, PhD, Pradeep Natarajan, MD, Diego Ardissino, MD, John Danesh, FRCP DPhil, Heribert Schunkert, MD, Adolfo Correa, MD PhD, Matthew J. Bown, MD FRCS, Nilesh J. Samani, MD FRCP, Jeanette Erdmann, PhD, Ruth McPherson, MD, Hugh Watkins, MD PhD, Danish Saleheen, MD, Roberto Elosua, MD PhD, Masa-aki Kawashiri, MD PhD, Hayato Tada, MD PhD, Namrata Gupta, PhD, Svati H. Shah, MD MHS, Daniel J. Rader, MD, Stacey Gabriel, PhD, Amit V. Khera*, MD, Sekar Kathiresan*, MD *: These authors contributed equally Address for correspondence: Sekar Kathiresan, MD Verve Therapeutics 26 Landsdowne Street, 1st Floor Cambridge, MA 02139 Email: [email protected] Phone: 617 603 0070 bioRxiv preprint doi: https://doi.org/10.1101/780734; this version posted September 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Background: Familial sitosterolemia is a rare, recessive Mendelian disorder characterized by hyperabsorption and decreased biliary excretion of dietary sterols.
    [Show full text]
  • The Expression of the Human Apolipoprotein Genes and Their Regulation by Ppars
    CORE Metadata, citation and similar papers at core.ac.uk Provided by UEF Electronic Publications The expression of the human apolipoprotein genes and their regulation by PPARs Juuso Uski M.Sc. Thesis Biochemistry Department of Biosciences University of Kuopio June 2008 Abstract The expression of the human apolipoprotein genes and their regulation by PPARs. UNIVERSITY OF KUOPIO, the Faculty of Natural and Environmental Sciences, Curriculum of Biochemistry USKI Juuso Oskari Thesis for Master of Science degree Supervisors Prof. Carsten Carlberg, Ph.D. Merja Heinäniemi, Ph.D. June 2008 Keywords: nuclear receptors; peroxisome proliferator-activated receptor; PPAR response element; apolipoprotein; lipid metabolism; high density lipoprotein; low density lipoprotein. Lipids are any fat-soluble, naturally-occurring molecules and one of their main biological functions is energy storage. Lipoproteins carry hydrophobic lipids in the water and salt-based blood environment for processing and energy supply in liver and other organs. In this study, the genomic area around the apolipoprotein genes was scanned in silico for PPAR response elements (PPREs) using the in vitro data-based computer program. Several new putative REs were found in surroundings of multiple lipoprotein genes. The responsiveness of those apolipoprotein genes to the PPAR ligands GW501516, rosiglitazone and GW7647 in the HepG2, HEK293 and THP-1 cell lines were tested with real-time PCR. The APOA1, APOA2, APOB, APOD, APOE, APOF, APOL1, APOL3, APOL5 and APOL6 genes were found to be regulated by PPARs in direct or secondary manners. Those results provide new insights in the understanding of lipid metabolism and so many lifestyle diseases like atherosclerosis, type 2 diabetes, heart disease and stroke.
    [Show full text]
  • The Effect of Statin Treatment on Intratumoral Cholesterol Levels and LDL Receptor Expression: a Window-Of-Opportunity Breast Ca
    Feldt et al. Cancer & Metabolism (2020) 8:25 https://doi.org/10.1186/s40170-020-00231-8 RESEARCH Open Access The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of- opportunity breast cancer trial Maria Feldt1,2* , Julien Menard1, Ann H. Rosendahl1,2, Barbara Lettiero1, Pär-Ola Bendahl1, Mattias Belting1,2,3 and Signe Borgquist1,4 Abstract Background: Deregulated lipid metabolism is common in cancer cells and the mevalonate pathway, which synthesizes cholesterol, is central in lipid metabolism. This study aimed to assess statin-induced changes of the intratumoral levels of cholesterol and the expression of the low-density lipoprotein receptor (LDLR) to enhance our understanding of the role of the mevalonate pathway in cancer cholesterol metabolism. Methods: This study is based on a phase II clinical trial designed as a window-of-opportunity trial including 50 breast cancer patients treated with 80 mg of atorvastatin/day for 2 weeks, between the time of diagnosis and breast surgery. Lipids were extracted from frozen tumor tissue sampled pre- and post-atorvastatin treatment. Intratumoral cholesterol levels were measured using a fluorometric quantitation assay. LDLR expression was evaluated by immunohistochemistry on formalin-fixed paraffin-embedded tumor tissue. Paired blood samples pre- and post- atorvastatin were analyzed for circulating low-density lipoprotein (LDL), high-density lipoprotein (HDL), apolipoprotein A1, and apolipoprotein B. In vitro experiments on MCF-7 breast cancer cells treated with atorvastatin were performed for comparison on the cellular level. Results: In the trial, 42 patients completed all study parts. From the paired tumor tissue samples, assessment of the cholesterol levels was achievable for 14 tumors, and for the LDLR expression in 24 tumors.
    [Show full text]
  • Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease
    International Journal of Molecular Sciences Review Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease Stanislav Kotlyarov Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia; [email protected] Abstract: Chronic obstructive pulmonary disease (COPD) is the important medical and social problem. According to modern concepts, COPD is a chronic inflammatory disease, macrophages play a key role in its pathogenesis. Macrophages are heterogeneous in their functions, which is largely determined by their immunometabolic profile, as well as the features of lipid homeostasis, in which the ATP binding cassette transporter A1 (ABCA1) plays an essential role. The objective of this work is the analysis of the ABCA1 protein participation and the function of reverse cholesterol transport in the pathogenesis of COPD. The expression of the ABCA1 gene in lung tissues takes the second place after the liver, which indicates the important role of the carrier in lung function. The participation of the transporter in the development of COPD consists in provision of lipid metabolism, regulation of inflammation, phagocytosis, and apoptosis. Violation of the processes in which ABCA1 is involved may be a part of the pathophysiological mechanisms, leading to the formation of a heterogeneous clinical course of the disease. Keywords: chronic obstructive pulmonary disease; COPD; inflammation; ABCA1; reverse cholesterol transport; innate immune system Citation: Kotlyarov, S. Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive 1. Introduction Pulmonary Disease. Int. J. Mol. Sci. Chronic obstructive pulmonary disease (COPD) is one of the most widespread dis- 2021, 22, 3334. https://doi.org/ eases, it has great medical significance due to the high frequency of temporary and per- 10.3390/ijms22073334 sistent disability and mortality.
    [Show full text]
  • 1 CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on A
    Page 1 of 55 Diabetes CETP inhibition improves HDL function but leads to fatty liver and insulin resistance in CETP-expressing transgenic mice on a high-fat diet Lin Zhu1,2, Thao Luu2, Christopher H. Emfinger1,2, Bryan A Parks5, Jeanne Shi2,7, Elijah Trefts3, Fenghua Zeng4, Zsuzsanna Kuklenyik5, Raymond C. Harris4, David H. Wasserman3, Sergio Fazio6 and John M. Stafford1,2,3,* 1VA Tennessee Valley Healthcare System, 2Division of Diabetes, Endocrinology, & Metabolism, 3Department of Molecular Physiology and Biophysics, 4Devision of Nephrology and Hypertension, Vanderbilt University School of Medicine. 5Division of Laboratory Sciences, Centers for Disease Control and Prevention. 6The Center for Preventive Cardiology at the Knight Cardiovascular Institute, Oregon Health & Science University. 7Trinity College of Art and Science, Duke University. * Address correspondence and request for reprints to: John. M. Stafford, 7445D Medical Research Building IV, Nashville, TN 37232-0475, phone (615) 936-6113, fax (615) 936- 1667 Email: [email protected] Running Title: CETP inhibition and insulin resistance Word Count: 5439 Figures: 7 Tables: 1 1 Diabetes Publish Ahead of Print, published online September 13, 2018 Diabetes Page 2 of 55 Abstract In clinical trials inhibition of cholesteryl ester transfer protein (CETP) raises HDL cholesterol levels but doesn’t robustly improve cardiovascular outcomes. About 2/3 of trial participants were obese. Lower plasma CETP activity is associated with increased cardiovascular risk in human studies, and protective aspects of CETP have been observed in mice fed a high-fat diet (HFD) with regard to metabolic outcomes. To define if CETP inhibition has different effects depending on the presence of obesity, we performed short- term anacetrapib treatment in chow- and HFD-fed CETP-transgenic mice.
    [Show full text]
  • An Abundant Dysfunctional Apolipoprotein A1 in Human Atheroma
    Cleveland State University EngagedScholarship@CSU Mathematics Faculty Publications Mathematics Department 2-1-2014 An Abundant Dysfunctional Apolipoprotein A1 in Human Atheroma Ying Huang Cleveland Clinic Joseph A. DiDonato Cleveland State University, [email protected] Bruce S. Levison Cleveland Clinic Dave Schmitt Cleveland Clinic Lin Li Cleveland Clinic Follow this and additional works at: https://engagedscholarship.csuohio.edu/scimath_facpub Part of the Mathematics Commons See next page for additional authors How does access to this work benefit ou?y Let us know! Repository Citation Huang, Ying; DiDonato, Joseph A.; Levison, Bruce S.; Schmitt, Dave; Li, Lin; Wu, Yuping; Buffa, Jennifer; Kim, Timothy; Gerstenecker, Gary S.; Gu, Xiaodong; Kadiyala, Chandra S.; Wang, Zeneng; Culley, Miranda K.; Hazen, Jennie E.; DiDonato, Anthony J.; Fu, Xiaoming; Berisha, Stela Z.; Peng, Daoquan; Nguyen, Truc T.; Liang, Shaohong; Chuang, Chia-Chi; Cho, Leslie; PLow, Edward F.; Fox, Paul L.; Gogonea, Valentin; Tang, W.H. Wilson; Parks, John S.; Fisher, Edward A.; Smith, Jonathan D.; and Hazen, Stanley L., "An Abundant Dysfunctional Apolipoprotein A1 in Human Atheroma" (2014). Mathematics Faculty Publications. 161. https://engagedscholarship.csuohio.edu/scimath_facpub/161 This Article is brought to you for free and open access by the Mathematics Department at EngagedScholarship@CSU. It has been accepted for inclusion in Mathematics Faculty Publications by an authorized administrator of EngagedScholarship@CSU. For more information, please contact [email protected]. Authors Ying Huang, Joseph A. DiDonato, Bruce S. Levison, Dave Schmitt, Lin Li, Yuping Wu, Jennifer Buffa, Timothy Kim, Gary S. Gerstenecker, Xiaodong Gu, Chandra S. Kadiyala, Zeneng Wang, Miranda K. Culley, Jennie E.
    [Show full text]
  • Clusterin and LRP2 Are Critical Components of the Hypothalamic Feeding Regulatory Pathway
    ARTICLE Received 21 Sep 2012 | Accepted 16 Apr 2013 | Published 14 May 2013 DOI: 10.1038/ncomms2896 Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway So Young Gil1, Byung-Soo Youn2, Kyunghee Byun3,4, Hu Huang5, Churl Namkoong1, Pil-Geum Jang1, Joo-Yong Lee1, Young-Hwan Jo6, Gil Myoung Kang1, Hyun-Kyong Kim1, Mi-Seon Shin7, Claus U. Pietrzik8, Bonghee Lee3,4, Young-Bum Kim3,5 & Min-Seon Kim1,7 Hypothalamic feeding circuits are essential for the maintenance of energy balance. There have been intensive efforts to discover new biological molecules involved in these pathways. Here we report that central administration of clusterin, also called apolipoprotein J, causes anorexia, weight loss and activation of hypothalamic signal transduction-activated transcript-3 in mice. In contrast, inhibition of hypothalamic clusterin action results in increased food intake and body weight, leading to adiposity. These effects are likely mediated through the mutual actions of the low-density lipoprotein receptor-related protein-2, a potential receptor for clusterin, and the long-form leptin receptor. In response to clusterin, the low-density lipoprotein receptor-related protein-2 binding to long-form leptin receptor is greatly enhanced in cultured neuronal cells. Furthermore, long-form leptin receptor deficiency or hypothalamic low-density lipoprotein receptor-related protein-2 suppression in mice leads to impaired hypothalamic clusterin signalling and actions. Our study identifies the hypotha- lamic clusterin–low-density lipoprotein receptor-related protein-2 axis as a novel anorexigenic signalling pathway that is tightly coupled with long-form leptin receptor-mediated signalling. 1 Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul 138-736, Korea.
    [Show full text]
  • Bio-Plex Pro™ Human Apolipoprotein 10-Plex Assay
    Metabolism Cancer Cardiovascular Disease Cytokines, Chemokines, Growth Factors Neurology Diabetes Infectious Disease ™ Inflammation Bio-Plex Pro Signal Transduction Sepsis Human Apolipoprotein 10-Plex Assay Apolipoprotein A1 / Apolipoprotein A2 / Apolipoprotein B / Apolipoprotein C1 / Apolipoprotein C3 MAGNETIC SEPARATION ENABLED Apolipoprotein D / Apolipoprotein E / Apolipoprotein H / Apolipoprotein J / C-Reactive Protein ■ All-in-one High-Performance Multiplex Assay Features premixed kit Immunoassays for Research This panel is offered in a convenient, ■ Optimized The Bio-Plex Pro Human Apolipoprotein Assay all-in-one, 10-plex kit format that includes for lot-to-lot Panel is a sensitive, magnetic bead–based magnetic capture beads, detection antibodies, reproducibility multiplex assay that allows you to accurately vial of standards, two-level controls, diluents, ■ Two-level measure nine apolipoproteins and C-reactive buffers, streptavidin-PE, flat bottom plate, and quality controls protein (CRP) in diverse matrices, including plate seals for the detection of nine human ■ Magnetic workflow serum and plasma. Multiplex capabilities apolipoproteins and CRP (Table 1). allow you to rapidly quantitate multiple ■■ Manufactured in accordance with apolipoproteins in a single microplate well GMP guidelines in just 4 hours, using only 10 µl of sample. ■■ Lot-to-lot correlation specification of Validated to rigorous analytical standards and R2 ≥ 0.9 for consistent, reproducible results designed for lot-to-lot consistency, this panel ■■ Full multiplate
    [Show full text]
  • Brain-Specific Lipoprotein Receptors Interact with Astrocyte Derived
    ARTICLE https://doi.org/10.1038/s41467-021-22751-7 OPEN Brain-specific lipoprotein receptors interact with astrocyte derived apolipoprotein and mediate neuron-glia lipid shuttling Jun Yin1, Emma Spillman1,5, Ethan S. Cheng1, Jacob Short 1, Yang Chen1, Jingce Lei1, Mary Gibbs1, Justin S. Rosenthal1, Chengyu Sheng 1,6, Yuki X. Chen2,3, Kelly Veerasammy2,3, Tenzin Choetso2,3, ✉ Rinat Abzalimov2, Bei Wang 4, Chun Han 4,YeHe2 & Quan Yuan 1 1234567890():,; Lipid shuttling between neurons and glia contributes to the development, function, and stress responses of the nervous system. To understand how a neuron acquires its lipid supply from specific lipoproteins and their receptors, we perform combined genetic, transcriptome, and biochemical analyses in the developing Drosophila larval brain. Here we report, the astrocyte- derived secreted lipocalin Glial Lazarillo (GLaz), a homolog of human Apolipoprotein D (APOD), and its neuronal receptor, the brain-specific short isoforms of Drosophila lipophorin receptor 1 (LpR1-short), cooperatively mediate neuron-glia lipid shuttling and support den- drite morphogenesis. The isoform specificity of LpR1 defines its distribution, binding partners, and ability to support proper dendrite growth and synaptic connectivity. By demonstrating physical and functional interactions between GLaz/APOD and LpR1, we elucidate molecular pathways mediating lipid trafficking in the fly brain, and provide in vivo evidence indicating isoform-specific expression of lipoprotein receptors as a key mechanism for regulating cell- type specific lipid recruitment. 1 Dendrite Morphogenesis and Plasticity Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. 2 The City University of New York, Graduate Center-Advanced Science Research Center, New York, NY, USA.
    [Show full text]
  • Increased Phospholipid Transfer Protein Activity Associated with the Impaired Cellular Cholesterol Efflux in Type 2 Diabetic Subjects with Coronary Artery Disease
    Tohoku J. Exp. Med., 2007,Cholesterol 213, 129-137 Efflux and PLTP Activity in Diabetes with CAD 129 Increased Phospholipid Transfer Protein Activity Associated with the Impaired Cellular Cholesterol Efflux in Type 2 Diabetic Subjects with Coronary Artery Disease 1,2 2 2 2 3 NEBIL ATTIA, AMEL NAKBI, MAHA SMAOUI, RAJA CHAABA, PHILIPPE MOULIN, 4 4 5 SONIA HAMMAMI, KHALDOUN BEN HAMDA, FRANÇOISE CHANUSSOT and 2 MOHAMED HAMMAMI 1Biology Department, Faculty of Sciences, University November 7th at Carthage, Bizerte, Tunisia 2Biochemistry Laboratory, UR 08-39, Faculty of Medicine, University of Monastir, Monastir, Tunisia 3U11 Cardiovascular Unit, Louis Pradel Hospital and INSERM U585, Lyon, France 4Departments of Internal Medicine (SH) and Cardiology (KBH), Monastir Hospital, Monastir, Tunisia 5INSERM U476, Faculty of Medecine la Timone, University Aix-Marseille II, Marseille, France ATTIA, N., NAKBI, A., SMAOUI, M., CHAABA, R., MOULIN, P., HAMMAMI, S., HAMDA, K.B., CHANUSSOT, F. and HAMMAMI, M. Increased Phospholipid Transfer Protein Activity Associated with the Impaired Cellular Cholesterol Efflux in Type 2 Diabetic Subjects with Coronary Artery Disease. Tohoku J. Exp. Med., 2007, 213 (2), 129-137 ── Reverse cholesterol transport (RCT) is the pathway, by which the excess of cholesterol is removed from peripheral cells to the liver. An early step of RCT is the efflux of free cholesterol from cell membranes that is mediated by high-density lipoproteins (HDL). Phospholipid transfer protein (PLTP) transfers phospholipids between apolipoprotein-B-containing lipo- proteins (i.e., chylomicrons and very low-density lipoproteins) and HDL. PLTP contrib- utes to the HDL maturation and increases the ability of HDL to extract the cellular choles- terol.
    [Show full text]
  • Common Genetic Variations Involved in the Inter-Individual Variability Of
    nutrients Review Common Genetic Variations Involved in the Inter-Individual Variability of Circulating Cholesterol Concentrations in Response to Diets: A Narrative Review of Recent Evidence Mohammad M. H. Abdullah 1 , Itzel Vazquez-Vidal 2, David J. Baer 3, James D. House 4 , Peter J. H. Jones 5 and Charles Desmarchelier 6,* 1 Department of Food Science and Nutrition, Kuwait University, Kuwait City 10002, Kuwait; [email protected] 2 Richardson Centre for Functional Foods & Nutraceuticals, University of Manitoba, Winnipeg, MB R3T 6C5, Canada; [email protected] 3 United States Department of Agriculture, Agricultural Research Service, Beltsville, MD 20705, USA; [email protected] 4 Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada; [email protected] 5 Nutritional Fundamentals for Health, Vaudreuil-Dorion, QC J7V 5V5, Canada; [email protected] 6 Aix Marseille University, INRAE, INSERM, C2VN, 13005 Marseille, France * Correspondence: [email protected] Abstract: The number of nutrigenetic studies dedicated to the identification of single nucleotide Citation: Abdullah, M.M.H.; polymorphisms (SNPs) modulating blood lipid profiles in response to dietary interventions has Vazquez-Vidal, I.; Baer, D.J.; House, increased considerably over the last decade. However, the robustness of the evidence-based sci- J.D.; Jones, P.J.H.; Desmarchelier, C. ence supporting the area remains to be evaluated. The objective of this review was to present Common Genetic Variations Involved recent findings concerning the effects of interactions between SNPs in genes involved in cholesterol in the Inter-Individual Variability of metabolism and transport, and dietary intakes or interventions on circulating cholesterol concen- Circulating Cholesterol trations, which are causally involved in cardiovascular diseases and established biomarkers of Concentrations in Response to Diets: cardiovascular health.
    [Show full text]
  • Convergence of Genes Implicated in Alzheimer's Disease on the Cerebral
    Neurochemistry International 50 (2007) 12–38 www.elsevier.com/locate/neuint Review Convergence of genes implicated in Alzheimer’s disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis C.J. Carter 176 Downs Road, Hastings, East Sussex TN34 2DZ, UK Received 5 April 2006; received in revised form 30 June 2006; accepted 11 July 2006 Available online 12 September 2006 Abstract Polymorphic genes associated with Alzheimer’s disease (see www.polygenicpathways.co.uk) delineate a clearly defined pathway related to cerebral and peripheral cholesterol and lipoprotein homoeostasis. They include all of the key components of a glia/neurone cholesterol shuttle including cholesterol binding lipoproteins APOA1, APOA4, APOC1, APOC2, APOC3, APOD, APOE and LPA, cholesterol transporters ABCA1, ABCA2, lipoprotein receptors LDLR, LRP1, LRP8 and VLDLR, and the cholesterol metabolising enzymes CYP46A1 and CH25H, whose oxysterol products activate the liver X receptor NR1H2 and are metabolised to esters by SOAT1. LIPA metabolises cholesterol esters, which are transported by the cholesteryl ester transport protein CETP. The transcription factor SREBF1 controls the expression of most enzymes of cholesterol synthesis. APP is involved in this shuttle as it metabolises cholesterol to 7-betahydroxycholesterol, a substrate of SOAT1 and HSD11B1, binds to APOE and is tethered to LRP1 via APPB1, APBB2 and APBB3 at the cytoplasmic domain and via LRPAP1 at the extracellular domain. APP cleavage products are also able to prevent cholesterol binding to APOE. BACE cleaves both APP and LRP1. Gamma-secretase (PSEN1, PSEN2, NCSTN) cleaves LRP1 and LRP8 as well as APP and their degradation products control transcription factor TFCP2, which regulates thymidylate synthase (TS) and GSK3B expression.
    [Show full text]